Healthcare

Firebrick Pharma announced that it has secured firm commitments from investors to raise approximately AUD 1.5 million through aplacementof new shares. The capital raise met its target, with participation from both new and existing sophisticated investors.

Nexsen Limited (ASX:NXN) shares advanced 9.09% to AUD 0.18 during the afternoon session on 31 March 2026. The upward movement follows the announcement that the Company has secured a HK$6 million (approximately AUD 1.2 million) IGNITE Grant to fund its expansion into the Asia-Pacific …

On Tuesday 31 March 2026, American Uranium Ltd (ASX:AMU) delivered a sharp and material single-session share price gain, closing at $0.135 — up $0.030 or 28.57% — on volume of 526,468 shares. The bid and offer range at the close sat at $0.135 on …

Racura Oncology Ltd (ASX:RAC) shares gained 3.29% to AUD 2.51 on 31 March 2026, extending a favourable 12-month rally of 134.58%, as investors responded to a key clinical development update.

Telix Pharmaceuticals Limited (ASX:TLX) posted a notable share performance on recent trading at $13.45 with a 3.14% gain amid market volume exceeding 400,000 shares. These movements coincide with a strategic regulatory development announced on 16 March 2026 — the resubmission of a New Drug …

The investment narrative for Hydrix has fundamentally shifted multiple times over the company's history, from optimism regarding product commercialization to struggles accessing capital markets and achievingrevenuegrowth. The company's current micro-cap status and depressed valuation reflect years of disappointing financial results, challenges commercializing medical devices, …

Understanding why a stock trades at its all-time low requires a multifaceted approach that goes beyond simply looking at the share price. Investors must consider the company's underlying business model, the health of its balance sheet, the dynamics of the industry in which it …